CRED NPM

06/11/2024

What were the Issues that Led to the Withdrawal of the Centralised Switch?

1

2

Ability of the patient to self diagnose the underlying conditions (possibly resulting in delay in diagnosis and treatment),

Ability of the Consumer to correctly assess the warnings and the contra-indications

4

3

Effect of the change of the classification on the magnitude of the incorrect use (particularly in young patients)

Need for medical advice to be given to patients who require a treatment initiation with a lower dose

CHMP also expressed concern around the role of the pharmacist, given the diversity of pharmacy practice across Europe. 5

The Organisation for Professionals in Regulatory Affairs

11

1. Ability to Self Diagnose any Underlying Conditions (possibly resulting in delay of diagnosis and treatment)

• Concerns were raised that ED can be a precursor symptom of more serious underlying disease and that self management of ED could risk delay in diagnosis and treatment of the underlying disease • ED can be a precursor symptom of Cardiovascular disease (CVD) and/or diabetes • BUT awareness in men of this association is low, with ED seen as a sexual problem and not an indicator of overall health status

The Organisation for Professionals in Regulatory Affairs

12

6